Page 117 - 《中国药房》2025年10期

参考文献 large prospective cohort[J]. PLoS One，2020，15（5）：
[ 1 ] Pharmaceutical Care Network Europe （PCNE）. The e0230215.
PCNE classification V9.0 in Chinese Translation Manda‐ [12] HØJ K，PEDERSEN H S，LUNDBERG A S B，et al. Ex‐
rin 2019 [EB/OL]. [2024-12-01]. https：//www.pcne.org/ ternal validation of the Medication Risk Score in polyphar‐
upload/files/555_09_PCNE_classification_V9-1_final.pdf. macy patients in general practice：a tool for prioritizing pa‐
[ 2 ] MOONS K G M，DE GROOT J A H，BOUWMEESTER tients at greatest risk of potential drug-related problems[J].
W，et al. Critical appraisal and data extraction for systema- Basic Clin Pharmacol Toxicol，2021，129（4）：319-331.
tic reviews of prediction modelling studies：the CHARMS [13] TAYLOR S E，MITRI E A，HARDING A M，et al. Deve-
checklist[J]. PLoS Med，2014，11（10）：e1001744. lopment of screening tools to predict medication-related
problems across the continuum of emergency department
[ 3 ] WOLFF R F，MOONS K G M，RILEY R D，et al.
PROBAST：a tool to assess the risk of bias and applica- care：a prospective，multicenter study[J]. Front Pharmacol，
2022，13：865769.
bility of prediction model studies[J]. Ann Intern Med，
[14] 彭杨，朱必敏，刘睿，等. 终末期肾病患者用药风险预测
2019，170（1）：51-58.
模型的构建及评价[J]. 实用药物与临床，2023，26（8）：
[ 4 ] ROTEN I，MARTY S，BENEY J. Electronic screening of
699-704.
medical records to detect inpatients at risk of drug-related
[15] 杨碧香，杨森宾，杨志伟. 老年2型糖尿病药物相关问题
problems[J]. Pharm World Sci，2010，32（1）：103-107.
现状以及风险预测模型的构建与验证[J]. 实用中西医结
[ 5 ] URBINA O，FERRÁNDEZ O，GRAU S，et al. Design of
合临床，2023，23（14）：1-4，71.
a score to identify hospitalized patients at risk of drug-
[16] 朱必敏，赵平，张露，等 . 基于风险预测模型指导 2 型糖
related problems[J]. Pharmacoepidemiol Drug Saf，2014，
尿病患者药物治疗管理模式构建及评价研究[J]. 实用药
23（9）：923-932.
物与临床，2023，26（11）：1004-1009.
[ 6 ] URBINA O，FERRÁNDEZ O，LUQUE S，et al. Patient
[17] BOBROVA V，FIALOVÁ D，DESSELLE S，et al. Identi‐
risk factors for developing a drug-related problem in a car‐
fying potential drug-related problems among geriatric pa‐
diology ward[J]. Ther Clin Risk Manag，2014，11：9-15.
tients with use of an integrated clinical decision support
[ 7 ] FERRÁNDEZ O，GRAU S，URBINA O，et al. Validation
tool[J]. Front Pharmacol，2022，13：761787.
of a score to identify inpatients at risk of a drug-related
[18] SEVERSON K A，CHAHINE L M，SMOLENSKY L A，
problem during a 4-year period[J]. Saudi Pharm J，2018，
et al. Discovery of Parkinson’s disease states and disease
26（5）：703-708.
progression modelling：a longitudinal data study using ma‐
[ 8 ] KAUFMANN C P，STÄMPFLI D，MORY N，et al. Drug-
chine learning[J]. Lancet Digit Health，2021，3（9）：e555-
associated risk tool：development and validation of a self-
e564.
assessment questionnaire to screen for hospitalised pa‐
[19] SCHWARTZMANN B，DHAMI P，UHER R，et al. Deve-
tients at risk for drug-related problems[J]. BMJ Open，
loping an electroencephalography-based model for predic-
2018，8（3）：e016610.
ting response to antidepressant medication[J]. JAMA
[ 9 ] STÄMPFLI D，BOENI F，GERBER A，et al. Assessing
Netw Open，2023，6（9）：e2336094.
the ability of the Drug-Associated Risk Tool（DART）ques‐
[20] LEOPOLDINO R D，SANTOS M T，COSTA T X，et al.
tionnaire to stratify hospitalised older patients according Risk assessment of patient factors and medications for
to their risk of drug-related problems：a cross-sectional drug-related problems from a prospective longitudinal
validation study[J]. BMJ Open，2018，8（6）：e021284. study of newborns admitted to a neonatal intensive care
[10] GEESON C，WEI L，FRANKLIN B D. Development and unit in Brazil[J]. BMJ Open，2019，9（7）：e024377.
performance evaluation of the medicines optimisation as‐ [21] VALE BEZERRA P K，CHAVES CAVALCANTI J E，
sessment tool（MOAT）：a prognostic model to target hos‐ CARLETE FILHO S R，et al. Drug-related problems in
pital pharmacists’ input to prevent medication-related hypertension and gestational diabetes mellitus：a hospital
problems[J]. BMJ Qual Saf，2019，28（8）：645-656. cohort[J]. PLoS One，2023，18（4）：e0284053.
[11] SALDANHA V，ARAÚJO I B，LIMA S I V C，et al. Risk （收稿日期：2024-12-17 修回日期：2025-04-25）
factors for drug-related problems in a general hospital：a （编辑：陈 宏）

中国药房 2025年第36卷第10期 China Pharmacy 2025 Vol. 36 No. 10 · 1259 ·